Sec. 3. Overdose prevention programs
1,234 words·~6 min read·
/bill/113/s/2755/is/section-3A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Title III of the Public Health Service Act ( 42 U.S.C. 241 et seq. ) is amended by adding at the end the following: The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall enter into cooperative agreements with eligible entities to enable the eligible entities to reduce deaths occurring from overdoses of drugs. To be eligible to receive a cooperative agreement under this section, an entity shall be a State, local, or tribal government, a correctional institution, a law enforcement agency, a community agency, a professional organization in the field of poison control and surveillance, or a private nonprofit organization.
An eligible entity desiring a cooperative agreement under this section shall submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require. An application under paragraph
(1)shall include— a description of the activities to be funded through the cooperative agreement; and evidence that the eligible entity has the capacity to carry out such activities. In entering into cooperative agreements under subsection (a), the Secretary shall give priority to eligible entities that— are a public health agency or community-based organization; and have expertise in preventing deaths occurring from overdoses of drugs in populations at high risk of such deaths. As a condition of receipt of a cooperative agreement under this section, an eligible entity shall agree to use the cooperative agreement to do each of the following: Purchase and distribute the drug naloxone or a similarly effective medication. Carry out one or more of the following activities: Educating prescribers and pharmacists about overdose prevention and naloxone prescription, or prescription of a similarly effective medication. Training first responders, other individuals in a position to respond to an overdose, and law enforcement and corrections officials on the effective response to individuals who have overdosed on drugs. Training pursuant to this subparagraph may include any activity that is educational, instructional, or consultative in nature, and may include volunteer training, awareness building exercises, outreach to individuals who are at-risk of a drug overdose, and distribution of educational materials. Implementing and enhancing programs to provide overdose prevention, recognition, treatment, and response to individuals in need of such services. Educating the public and providing outreach to the public about overdose prevention and naloxone prescriptions, or prescriptions of other similarly effective medications. The Secretary shall establish and provide for the operation of a coordinating center responsible for— collecting, compiling, and disseminating data on the programs and activities under this section, including tracking and evaluating the distribution and use of naloxone and other similarly effective medication; evaluating such data and, based on such evaluation, developing best practices for preventing deaths occurring from drug overdoses; making such best practices specific to the type of community involved; coordinating and harmonizing data collection measures; evaluating the effects of the program on overdose rates: and education and outreach to the public about overdose prevention and prescription of naloxone and other similarly effective medication. As a condition on receipt of a cooperative agreement under this section, an eligible entity shall agree to prepare and submit, not later than 90 days after the end of the cooperative agreement period, a report to such coordinating center and the Secretary describing the results of the activities supported through the cooperative agreement. The period of a cooperative agreement under this section shall be 4 years. In this part, the term drug means— a drug, as defined in section 201 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321 ); and includes controlled substances, as defined in section 102 of the Controlled Substances Act ( 21 U.S.C. 802 ). There are authorized to be appropriated $20,000,000 to carry out this section for each of the fiscal years 2015 through 2019. The Secretary, acting through the Director of the Centers for Disease Control and Prevention, shall award cooperative agreements to eligible entities to improve fatal and nonfatal drug overdose surveillance and reporting capabilities, including— providing training to improve identification of drug overdose as the cause of death by coroners and medical examiners; establishing, in cooperation with the National Poison Data System, coroners, and medical examiners, a comprehensive national program for surveillance of, and reporting to an electronic database on, drug overdose deaths in the United States; and establishing, in cooperation with the National Poison Data System, a comprehensive national program for surveillance of, and reporting to an electronic database on, fatal and nonfatal drug overdose occurrences, including epidemiological and toxicologic analysis and trends. To be eligible to receive a cooperative agreement under this section, an entity shall be— a State, local, or tribal government; or the National Poison Data System working in conjunction with a State, local, or tribal government. An eligible entity desiring a cooperative agreement under this section shall submit to the Secretary an application at such time, in such manner, and containing such information as the Secretary may require. The application described in paragraph
(1)shall include— a description of the activities to be funded through the cooperative agreement; and evidence that the eligible entity has the capacity to carry out such activities. As a condition of receipt of a cooperative agreement under this section, an eligible entity shall agree to prepare and submit, not later than 90 days after the end of the cooperative agreement period, a report to the Secretary describing the results of the activities supported through the cooperative agreement. In this section, the term National Poison Data System means the system operated by the American Association of Poison Control Centers, in partnership with the Centers for Disease Control and Prevention, for real-time local, State, and national electronic reporting, and the corresponding database network. There are authorized to be appropriated to carry out this section $5,000,000 for each of the fiscal years 2015 through 2019. Not later than 180 days after the date of the enactment of this section, the Secretary, in consultation with a task force comprised of stakeholders, shall develop a plan to reduce the number of deaths occurring from overdoses of drugs and shall submit the plan to Congress. The plan shall include— a plan for implementation of a public health campaign to educate prescribers and the public about overdose prevention and prescription of naloxone and other similarly effective medication; recommendations for improving and expanding overdose prevention programming; and recommendations for such legislative or administrative action as the Secretary determines appropriate. The task force under subsection
(a)shall include at least one representative of each of the following: Individuals directly impacted by drug overdose. Direct service providers who engage individuals at risk of a drug overdose. Drug overdose prevention advocates. The National Institute on Drug Abuse. The Center for Substance Abuse Treatment. The Centers for Disease Control and Prevention. The Health Resources and Services Administration. The Food and Drug Administration. The Office of National Drug Control Policy. The American Medical Association. The American Association of Poison Control Centers. The Federal Bureau of Prisons. The Centers for Medicare & Medicaid Services. The Department of Justice. The Department of Defense. The Department of Veterans Affairs. First responders. Law enforcement. State agencies responsible for drug overdose prevention. In addition to the representatives required by paragraph (1), the task force under subsection
(a)may include other individuals with expertise relating to drug overdoses or representatives of entities with expertise relating to drug overdoses, as the Secretary determines appropriate. .
Connectionstraces to 3
Traces to 3 documents
Citation graph
cites case law
Cites 3Cited by 0 across 0 sources